Loading...

UCB SA

UCBJF•PNK
Healthcare
Biotechnology
$275.25
$5.41(2.005%)
U.S. Market opens in 16h 22m

UCB SA (UCBJF) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap52.4B
P/E Ratio28.52
EPS (TTM)$9.42
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$259.95
3 Months$310.40
1 Year Target$253.24

UCBJF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $253.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.52 and a market capitalization of 52.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.005%
5-Day Change
0.63%
1-Month Change
-13.07%
3-Month Change
-13.13%
6-Month Change
11.88%
Year-to-Date (YTD) Change
-6.24%
1-Year Change
82.65%
3-Year Change
208.09%
5-Year Change
180.87%
All-Time (Max) Change
567.27%

Contact Information

https://www.ucb.com
32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 26, 2008
CountryBE
Actively Trading

Frequently Asked Questions